Markets in Geriatric Medicine Volume III: Cardiovascular Disease

Chapter One: Executive Summary

• Background
  • Scope and Methodology
  • Size and Growth of Market
  • Market Trends and Factors

Chapter Two: Introduction

• Background
• Population Demographics
• Epidemiology and Pathology
  • Hypertension
  • Atherosclerosis
  • Congestive Heart Failure

Chapter Three: Cardiovascular Therapeutics

• Background
• Current Approaches to Cardiovascular Disease Therapy
  • Patient Education
  • Exercise
  • Diet
  • Pharmaceutical Approaches
    • Hypertension
      • Diuretics
      • ß-Adrenergic Blockers
      • Angiotensin Converting Enzyme (ACE) Inhibitors
      • Calcium Channel Blockers
      • Angiotensin II Receptor Antagonists
    • Atherosclerosis
      • Fibric Acid Derivatives
      • HMG-CoA Reductase Inhibitors
      • Bile Acid Sequestrants
      • Nicotinic Acid
    • Congestive Heart Failure
    • Anti-Arrhythmic Drugs
    • Angiotensin Converting Enzyme (ACE) Inhibitors
    • Angiotensin II Receptor Antagonists
    • a/ß-Adrenergic Blockers
    • Diuretics
    • Inotropic Drugs
    • Vasodilators
• Device Approaches to Congestive Heart Failure
  • Pacemakers
  • Implantable Cardioverters/Defibrillators
  • Ventricular Assist Devices
• Emerging Therapeutic Approaches
• Hypertension
  • Diuretics
  • ß-Adrenergic Blockers
  • Angiotensin Converting Enzyme (ACE) Inhibitors
  • Calcium Channel Blockers
  • Angiotensin II Receptor Antagonists
  • Others
• Atherosclerosis
  • Fibric Acid Derivatives
  • HMG-CoA Reductase Inhibitors
  • Bile Acid Sequestrants
  • Nicotinic Acid
  • Others
• Congestive Heart Failure
  • Anti-Arrhythmic Drugs
  • Antihypertensive Drugs
  • Inotropic Drugs
  • Vasodilators
  • Biotechnology
    • Immunoglobulins
    • Parvalbumin
    • Myoblasts
    • Stem Cells (Cardiomyocytes)
    • Autoregeneration
    • Gene Therapy
• Devices
  • Heart Jackets
  • Heart Pumps
  • Resynchronization Systems
  • Ventricular Patches

Chapter Four: Market Analysis

• Market Size and Growth
  • Overview
  • Hypertension
  • Atherosclerosis
  • Congestive Heart Failure
• Competitive Outlook
  • Overview
  • Pharmaceuticals
    • Hypertension
    • Atherosclerosis
    • Congestive Heart Failure
  • Congestive Heart Failure Devices
• Market Trends

Chapter Five: Company Profiles

• Overview
• Abbott Laboratories
• Abiomed
• Acorn Cardiovascular
• Actelion, Ltd.
• Arrow International
• AstraZeneca
• Aventis
• Bioheart, Inc.
• Bristol-Myers Squibb
• Cardioenergetics
• CV Therapeutics
• GenVec, Inc.
• Geron Corporation
• GlaxoSmithKline
• Guidant Corporation
• Medigene AG
• Medtronic, Inc.
• Merck & Co.
• Micromed Technology, Inc.
• Myocor, Inc.
• Myogen
• Novartis
• Parke-Davis (Pfizer)
• Pfizer, Inc.
• St. Jude Medical
• Sankyo Pharma
• Somanetics Corporation
• Texas Biotechnology Corporation
• Thoratec Corporation
• Wyeth

Chapter Six: Conclusion and Strategic Implications

Appendix A: Company Names and Addresses